chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial misuse report received from a healthcare professional on 16 September 2013 and on 21 March 2014. A 68-year-old patient of unknown gender had received FLUZONE ID on an unknown date. The patient received FLUZONE ID at incorrect age. No adverse event was reported. The list of documents held by sender: None.
pain in left arm, swollen lymph node in the neck on the left side, measures approximately 1.5 cm, not painful, movable.
On 3/25/03 patient developed a HA, dizzy spells, with heart palpitations x 30 minutes.  Denies sob and cp.  Continues to suffer from malaise which had onset of 3/25/03
Headaches on and off since day after shot was given But begining on day the 4th day after the shot had vertigo for roughly 12 hours, came and went.  Since vertigo stopped headache has been nearly constant. Not depilitating, but constant.
Rec'd vaccine 10/21/08. Patient reports that on 10/22/08 there were red welts on her arms, legs, and hands which itched. No redness or reaction at the site of the injection. Her personal physician related the symptoms to the vaccine administration but did not prescribe any type of treatment. Patient did not report reaction to us(her employer)until today 10/28/08.
i have had flu-like symptoms for about a month, here are the details: Fever, chills, body aches,  brain fot, Lymphnodes in my neck are the size of golf balls, especially on right side of neck (opposite side of where I received the Johnson shot, in my left arm). Also, extreme fatigue.  The chills lasted for two weeks almost three, but are gone now. I had a fever off and on for three weeks as well.   One month later: I still have: extreme fatigue, Lymphnodes size of golf balls. The fatigue is very intense, and I can't really function.
NO INITIAL REACTION FROM SHOT - FELT GOOD - NORMAL ACTIVITIES DURING THE DAY.  HOWEVER, THAT NIGHT IN BED,SURPRISELY EXTREME CHEST PAINS/TIGHTNESS IN RIB CAGE .. NOT "CRUSHING" SO DID NOT GO THE EMERGENCY ROOM .. BUT DEFINITE TIGHTNESS NEVER FELT BEFORE .. HOWEVER, I WAS CONFIDENT THAT IT WAS JUST A VACCINE REACTION SO I USED RELAXATION TECHNIQUES AND FELL ASLEEP .. NEXT DAY, PAIN NOT AS SEVERE AND WAS GONE BY AFTERNOON.  DID NOT REPORT AT THE  TIME B/C DID NOT KNOW WHERE TO REPORT.  WHEN THE NEWS REPORTS WERE ISSUED ABOUT THE 6 PEOPLE, I PHONED MY DOCTOR ON APRIL 13 AND REPORTED MY REACTION.. THEN, THE NEXT DAY, ON APRIL 14, I GOT  A TEXT MESSAGE TO REPORT.  AND HERE IS MY REPORT.
It started with a runny nose and then the next day it was running more and by Tuesday morning, I was having a hard time breathing. I went to my PC and he sent me to the ER because I was so low on oxygen. They kept me there for about 6 hours to get the oxygen level to rise back up. My level went up so they sent me home. That night I had some afib with my heart and so the next morning when I woke up I was struggling to breath so that time they admitted. I was given oxygen. When the results for the blood panel and chest x-ray came back. I was given a different type of nose swab to detect more lung infections. I was diagnosed with Corona HD43. They placed me in isolation and started treatment. Due to the lactic acid, they gave me a medication to flush it out which made me go to the bathroom 60 times throughout the course of the night. My heart was still in afib. I was treated with antibiotics. I was in the hospital for 6 days. I was also treated with prednisone. I was discharged on 05-16.  I am still currently in oxygen. I have not yet fully recovered, I am scheduled to see a pulmonologist and my primary care physician on Monday.
Reported the onset of scattered 2-4mm papulovesicular lesions on extensor elbows, extensor forearms, and palmer surface of hands with an onset 17 days post vaccination with SPV on 14 May 12. Described as itchy bumps.
It was reported that a female pt received a TD Adult vaccination on 3/9/00. Reportedly, within 12 hours, the pt developed a rash over her entire body. From correspondence received on 3/27/00, additional pt and responsible physician information was provided.
Beginning evening of vaccination and lasting 24 hours; Fever                 Stomach pain with diarrhea                   Headache                    Chest pressure
2 X 2cm slightly hard swelling @ site. Fever 101.2 F orally.
left forearm cramping, progressed to left shoulder and upper back over next week;  symptoms have progressively worsened since that time
Vertigo; This is a spontaneous report from a non-contactable pharmacist, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, two weeks post the second vaccination, the patient experienced vertigo. The clinical outcome of the event vertigo was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
dose administered to patient after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021 at 3:53 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Oct-2021 at 3:53 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored in the fridge on 29-Sep-2021 or 05-Oct-2021, moved to clinic on 27-Oct-2021 and proposed beyond use date was 29-Oct-2021 or 04-Nov-2021 respectively.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit.  On 22-Oct-2021, at 08:00 A.M, 09:00 A.M and at 10:00 A.M. the temperature recorded was 32 degree Fahrenheit that has been reached by the vial.  On the date of administration, at 09:00 A.M., the temperature recorded was 29 degree Fahrenheit and at 10:00 A.M., the temperature recorded was 32 degree Fahrenheit that has been reached by the vial.  Temperature recordings were taken using a traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.   This case was linked to MOD-2022-566976 (Patient Link).
Unfortunately we did use this beyond the use date of 10/9/21.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Unfortunately we did use this beyond the use date of 10/9/21.) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Unfortunately we did use this beyond the use date of 10/9/21.). On 15-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Unfortunately we did use this beyond the use date of 10/9/21.) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications details were provided. No Treatment Medications details were provided.  This is a case of Expired Product Administered concerning a 73-year-old patient of an unknown gender with no relevant medical history, who experienced no other associated adverse events. The event occurred the same day after the third dose of mRNA-1273 Vaccine. The rechallenge was not applicable since events only happened after the third dose. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This is a case of Expired Product Administered concerning a 73-year-old patient of an unknown gender with no relevant medical history, who experienced no other associated adverse events. The event occurred the same day after the third dose of mRNA-1273 Vaccine. The rechallenge was not applicable since events only happened after the third dose. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
I had no symptoms until the next morning when I woke up with very extreme pain in my left arm with the epicenter of the pain on the back of my left hand between the bones leading to the ring finger and the pinky. Whenever my hand was below my heart, the entire hand was dark purple in color. I had read that severe reactions from the shot generally dissipated in a day so I took some Hydrocodone which I had for migraines, kept my hand elevated, and decided to wait it out. The next day the pain was still extreme so I went to urgent care. Urgent care eventually said I needed to go to the emergency room to have an ultra-sound. I did so. After many hours of waiting, they got me into the ultrasound room where they told me they cannot ultrasound the back of the hand because the vessels are too small and don?t show up. So they ran an ultrasound on the shoulder and front of the arm and found nothing. I?m not surprised as that is not where the pain was coming from. I went home and alternately put my left hand in ice water and hot water periodically, which eventually reduced the pain to a tolerable amount. As of today, all the pain is gone except for the region mentioned in the back of the hand. That still hurts, so I'm answering item 20 with a No.
Two days with headache, nausea, vomiting, malaise Treated with advil
6/18 4:36 AM Seen in ER with a temp of 104.3 and febrile seizure. Dx with febrile seizure and acute OM. Given Rx for AMOXIL. 6/18 Seen in ER with temp of 103.5 rectal and febrile seizure. Dx with febrile seizure and OM - given ROCEPHIN and Rx for AMOXIL. Returned to clinic 6/19/14 temp 98.4 - ears clear.
Information has been received from a certified medical assistant concerning a 23 to 25 year old female who on an unspecified date was vaccinated with a first dose of GARDASIL.  Subsequently, the patient experienced a painful, indented, discolored area where the first vaccination was administered.  On an unspecified date, the patient returned for the second vaccination with GARDASIL, and had a painful, white area a half dollar to dollar in size where the first vaccination was administered.  When the area was palpated, an indentation in the deltoid was noted.  The patient received the second dose of GARDASIL.  Additional information has been requested.
pt recv vax 30DEC96 & 1JAN97 pt exp a sz during which pt was limp for 1 1/2min & looked straight ahead;no fever or cold sx were noted; Followup information received. Information has been received from a physician concerning a 32 month old "otherwise healthy" hispanic female who on December 30, 1996 was vaccinated with a first dose of varicella vaccine SC in the left arm. There was no illness at the time of the vaccination. On January 1, 1997 the patient experienced a seizure, was pale with staring, during which patient was limp for 1 1/2 minutes. Patient was seen by a physician. No fever or cold symptoms were noted. Diagnostic tests revealed normal CT of the head and normal EEG. Subsequently, the patient recovered on January 2, 1997. No further details were provided.
shingles after first; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient recived the first dose and developed Shingles. The patient enquired if he/she could get another dose after developing shingles after the first dose.
Initially had a baseball sized painful swelling of the deltoid muscle which resolved after 5 days. On Friday August 20th pt. complained of a headache on his left side of his head. On Saturday morning he woke me up at 530am stating he needed to go to an ER for severe headache. En route to the rural ER that I am an RN at, he asked me to pull over so he could vomit a small amount. That was the last thing he rememberd for a 15 minute period. On resuming travel, he asked, "what does it feel like when you are about to have a seizure? because my muscles feel tense, my body feels weird and my brain is foggy.  he lost consciousness 3 times over the next 15 minutes. The first time his left arm jerked once, he stopped talking and answering me for about a minute.  A few minutes later he did it again. This time his respirations became fast and loud like a panting. He did not slump over like an unconscious person. I checked his pulse and kept my fingers on his wrist and called his name. He did not respond at all for about 2 minutes this time. On waking he was disoriented and emotional which is very out of character. He said, "where are we going?" When I told him we were going to the hospital and why, he began to sob and cry stating, "I can't remember! I can't remember!" About a mile before the hosptial, maybe 6-8 minutes later he lost consciousness one more time with the panting breathing for about 30 seconds. On waking he was normal again aside from the headache and nausea. He did not exhibit this again after arrival at the ED. He continued to have a headache throughout Sunday 8/22/21 and still has mild headache on Monday 8/23/21
Tinnitus about 3 days after receiving vaccine. In both ears. No relief and it's been months since first onset.
bursitis; tendonitis; pain in arm; pain in shoulder; trouble reising left arm; This case was reported by a consumer via call center representative and described the occurrence of bursitis in a male patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine (intramuscular). On an unknown date, several years after receiving Flu vaccine, the patient experienced bursitis, tendonitis, pain in arm, shoulder pain and injected limb mobility decreased. On an unknown date, the outcome of the bursitis, tendonitis and pain in arm were recovering/resolving and the outcome of the shoulder pain and injected limb mobility decreased were unknown.   It was unknown if the reporter considered the bursitis, tendonitis, pain in arm, shoulder pain and injected limb mobility decreased to be related to Flu vaccine.  Additional details were received as follows: The age vaccination was not reported. The patient did not know what brand flu vaccine was used. The patient refused to provide his address. The patient received a flu vaccine a few years ago from the time of reporting and experienced pain in his arm. The pain continued so the patient had an MRI that showed the shot had gone into the bursal sac, causing bursitis and tendonitis. Till the time of reporting the patient has a pain in shoulder and has trouble raising his left arm.      Lab Comments: On an unknown date MRI has been done
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a parent via social media concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) start therapy date were not reported, 1 total administrated for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, patient had the Johnson and Johnson and just got over the virus, it did not stop patient from not getting it (suspected covid-19 infection and suspected clinical vaccination failure). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20210644963-Covid 19 vaccine ad26.cov2.s- Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATION
This spontaneous report was received from a Registered Nurse, concerning a 15 year old female non-pregnant patient. The patient had a history of hives with ZITHROMAX in about 2006. The patient had no pertinent medical history or concomitant medications. On 12-MAR-2018, the patient was vaccinated with one dose of GARDASIL 9, intramuscular injection, to prevent Human Papilloma Virus (HPV) (lot number and expiration date were not reported). On about 17-APR-2018, the patient developed headache and a sore throat and on 24-APR-2018, she was diagnosed with mononucleosis. The patient sought medical attention and lab diagnostics were performed including blood tests and mono spot, however, the results were not provided. No treatment was given for the adverse event. By the time of the reporting, the patient was recovering from mononucleosis. The reporter did not assess the causal relationship between GARDASIL 9 and the event. This spontaneous report as received from a other health professional refers to a 15 year old female patient with urticaria. On, 1 DF, intramuscular for prophylaxis. On 17-APR-2018, 1 month 6 days after onset of therapy the patient experienced infectious mononucleosis. The outcome of infectious mononucleosis was reported as recovering/resolving. {Additional information has been requested./Additional information is not expected.}
Swelling from right shoulder to elbow right redness, warm to touch, tenderness, fluid filled blisters to margins where band aid were applied.
History of peanut allergies; carries EpiPen. Noted within 3-6 minutes following vaccine, had small rash on L inner wrist; arm where received vaccine. Chest appeared bit mottled; no apparent hive. BP 140/100, HR 140, no issues with breathing. After 5-10 minutes, took 25 mg liquid Benadryl; mottling resolved, wrist with same sized rash, L injection site with bit of redness/rash. BP 108/80, pulse 87, pulse ox 99% Taken to ED by w/c for further evaluation.
FLUAD WAS GIVEN IN PATIENT'S LEFT ARM, NO REACTION. PNEUMOVAX 23 WAS GIVEN IN RIGHT ARM. INSTANTLY, PATIENT'S LOWER CENTER BACK STARTED SPASMING AND RADIATING SHOOTING PAIN UP HIS BACK, LEADING TO FURTHER PAINFUL MUSCLE SPASMS. 911 WAS CALLED AND EMT ARRIVED MINUTES LATER. HE WAS ADMINISTERED A BENADRYL INJECTION PROPHYLACTICALLY. HIS VITALS WERE TAKEN AND EVERYTHING WAS STABLE. HE WAS RELEASED BY EMT.